Evaluation of 5-Fluorouracil Infusion with Mitomycin C vs 5-Fluorouracil Infusion with Methyl CCNU in the Treatment of Gastrointestinal Malignancies

Southwest Oncology Group experience with 5-fluorouracil in carcinoma of the colon.

JD McCracken;TT Chen;LP Leichman;VK Vaitkevicius 13th International Congress of Chemotherapy (Vienna, September 2, 1983), Part 259, SE 12.1 20-8

5-FU infusion with Mitomycin-C vs. 5-FU infusion with Methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest Oncology Group study.

T Buroker;P Kim;C Groppe;J McCracken;R O'Bryan;F Panettiere;J Costanzi;R Bottomley;G King;J Bonnet;T Thigpen;J Whitecar;C Haas;V Vaitkevicius;B Hoogstraten;L Heilbrun Cancer 44(4):1215-1221

The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treatment with chemo- therapy. A Southwest Oncology Group study.

M Al-Sarraf;L Baker;RW Talley;K Kithier;V Vaitkevicius Cancer 44:1222-1225

5-FU infusion with mitomycin-C versus 5-FU infusion with methyl-CCNU in the treatment of advanced colon cancer.

T Buroker;PN Kim;C Groppe;J Mccracken;R O'Bryan;F Panettiere;CA Coltman Jr;R Bottomley;H Wilson;J Bonnet;T Thigpen;VK Vaitkevicius;B Hoogstraten;L Heilburn Cancer 42(3):1228-1233

5-FU infusion with mitomycin-C vs. 5-FU infusion with methyl CCNU in the treatment of advanced colon cancer.

T Buroker;PN Ki;L Heilbrun;VK Vaitkevicius ASCO #C-18